Neurizon
Claremont
About Neurizon
Neurizon acquired Pitney Pharmaceuticals Ltd and raised funds to develop its product pipeline, which now includes both human and veterinary proprietary medicines to treat cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $21.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2025)
- Ticker: asx:PAA
- Website: pharmaust.com
- Phone: 61 8 9386 4787
Industries & Categories
Biotechnology, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/neurizon-135126 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.